Clinical context: current concepts of coronary heart disease management

Area of Science:

• Cardiology
• Public Health
• Pharmacoeconomics

Background:

• Coronary heart disease (CHD) is the leading cause of adult death in the US, incurring significant disability and economic costs.
• Elevated serum lipid levels, specifically low-density lipoprotein cholesterol (LDL-C), are strongly associated with CHD development.
• Nearly one-third of the US population has lipid levels that increase CHD risk.

Purpose of the Study:

• To review the efficacy and cost-effectiveness of statin therapy in managing elevated LDL-C and reducing cardiovascular disease (CVD) risk.
• To highlight the importance of optimizing statin therapy for cost-effectiveness in managing a large patient population.

Main Methods:

• Review of large-scale intervention studies on lipid-lowering therapies.
• Analysis of statin efficacy in reducing LDL-C, cardiovascular mortality, and adverse events.
• Evaluation of statin cost-effectiveness in the context of healthcare costs.

Main Results:

• Decreasing LDL-C levels through intervention studies significantly reduces cardiovascular mortality, adverse events, and revascularization needs.
• Statins are the most effective agents for lowering LDL-C, with additional benefits on other lipid profiles and good tolerability.
• Statin therapy is a cost-effective treatment for CVD, significantly decreasing disease risk.

Conclusions:

• Statin therapy is a highly effective and cost-effective strategy for reducing cardiovascular risk associated with elevated LDL-C.
• Optimizing the cost-effectiveness of statin therapy is crucial for managing healthcare costs, especially given the large number of eligible patients.